Please login to the form below

Not currently logged in
Email:
Password:

Peter Chambre joins cancer vaccine biotech Immatics

He replaces Thomas Widmann as chair of the board

Immatics Peter ChambreImmatics Biotechnologies has appointed Peter Chambré as chairman of the board to replace Thomas Widmann, who steps down after eight years in the post.

Chambré holds several chairman positions in the life sciences industry and previously served as CEO of Cambridge Antibody Technology from 2002 until its acquisition by AstraZeneca in 2006.

Paul Higham, CEO of Immatics, said: “I am delighted to welcome Peter as our new chairman. We are approaching a crucial period at Immatics, and Peter's experience and track record in successfully developing biopharmaceutical companies will be invaluable, as we seek to produce a step-change in the treatment of cancer and maximise returns to our investors.”

Chambré joins Tuebingen-based Immatics following the German biotech's recent completion of phase III patient enrollment for a trial of its therapeutic vaccine for renal cancer IMA901.

He said: “Immatics' vaccines, based on the company's highly rational approach to cancer vaccine discovery, have already demonstrated very promising results in clinical trials.

“With IMA901, Immatics' lead multi-peptide based vaccine now in phase III development for renal cancer, and a number of other projects in clinical development, this is an extremely exciting company.”

14th November 2012

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....
Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...